Abstract
Diabetic neuropathy (DN) is a common complication of diabetes mellitus and is associated with structural changes in the nerves. Nerve damage happen as a result of many factors including metabolic disorders, oxidative and nitrosative stress, changes in the blood vessels that supply the peripheral nerves and changes in ion channel expression in peripheral fibres. However, the molecular basis for DN is poorly understood. Adenosine monophosphate activated protein kinase (AMPK) has been shown to regulate the activity of some kinases including protein kinase B (AKT), mitogen-activated protein kinases (MAPK) and mammalian target of rapamycin complex 1 (mTORC1) that represent important signalling pathways modulating the function of peripheral nociceptive neurons. Donepezil can activate AMPK and exerts neuroprotective effects. Diabetic mice showed reduced expression of p-AMPK in sciatic nerves with consequent activation of AKT/MAPK/4EBP1. In addition, a significant upregulation of the N-Methyl-D-aspartate (NMDA) receptors in spinal cord of diabetic mice was observed. Therefore, Donepezil could be a potential pharmacological agent for management of DN.
Highlights
Diabetic neuropathy (DN) is the most common microvascular complication which progressively leads to neuronal degeneration
The mechanisms that cause diabetic neuropathic pain (DNP) are not fully understood, toxic effects of hyperglycaemia considered an important factor for the development of this complication (Oyibo et al, 2002)
Sorbitol is oxidized to fructose by sorbitol dehydrogenase enzyme, which is coupled with the reduction of nicotinamide adenine dinucleotide (NAD+) to NADH
Summary
Mostafab aSuez Canal University Teaching Hospitals, Ismailia, Egypt, bDepartment of Pharmacology & Toxicology, Faculty of Pharmacy, Suez Canal University, Ismailia 41522, Egypt, cDepartment of Cytology & Histology, Faculty of Veterinary Medicine, Suez Canal University, Ismailia, Egypt
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
